Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.900
+0.025 (2.90%)
At close: Dec 26, 2024, 4:00 PM
0.898
-0.002 (-0.18%)
After-hours: Dec 26, 2024, 6:41 PM EST
Acurx Pharmaceuticals Employees
Acurx Pharmaceuticals had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$4,108,975
Market Cap
15.20M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4 | 0 | - |
| Dec 31, 2022 | 4 | 1 | 33.33% |
| Dec 31, 2021 | 3 | 0 | - |
| Dec 31, 2020 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Marinus Pharmaceuticals | 166 |
| ProPhase Labs | 113 |
| Adagio Medical Holdings | 85 |
| bioAffinity Technologies | 75 |
| Aptose Biosciences | 36 |
| GlycoMimetics | 35 |
| Innovative Eyewear | 11 |
| Minerva Neurosciences | 9 |
ACXP News
- 15 days ago - Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 - January 30, 2025 - Accesswire
- 17 days ago - Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications - PRNewsWire
- 5 weeks ago - Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy's playbook - CNBC
- 5 weeks ago - Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset - PRNewsWire
- 5 weeks ago - Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update - PRNewsWire
- 6 weeks ago - Acurx Pharmaceuticals, Inc. (ACXP) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update - PRNewsWire
- 2 months ago - Acurx Ready To Expand Pipeline With Anthrax Treatment - Seeking Alpha